Contributors from the PKU community, including patient reps, key opinion leaders, and medical experts, discuss the implications of redefining ‘unmet medical need’ in the EU’s pharmaceutical legislation, emphasising the potential negative impact on patients, particularly those with rare diseases like phenylketonuria.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Med Ctr, explores the need for improved access to epilepsy surgery.
Dr Roderick Corriveau, PhD from the National Institute of Neurological Disorders & Stroke, part of the National Institutes of Health in the U.S., details the importance of understanding the many possible paths to dementia.
Yohei Sasakawa, Chairman of The Nippon Foundation, explores how COVID-19 has given us a glimpse of the lived experience of persons with disabilities and discusses why we have a duty to make the world more inclusive for them.
Neil Wright, on behalf of McGowan Transcriptions UK, discusses the benefits of bilingualism, specifically concerning how speaking more than one language can fight dementia.
Professor Olivier Braissant highlights here, how the challenges of treating genetic diseases can be exemplified by research on creatine transporter deficiency.
Gary Davies, from Sandvik Materials Technology, explains how medical wires are helping patients monitor blood glucose levels without the need for daily testing.
A new study from Children's Hospital Los Angeles has revealed a surge of pediatric patients presenting with diabetic ketoacidosis throughout the COVID-19 pandemic.
Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), drives the epilepsy field ahead with new research benchmarks, Vicky Whittemore, PhD, Program Director reveals.
